Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 421 to 432 of 432 entries
Sorted by: Best Match Show Resources per page
Human liver territories: Think beyond the 8-segments scheme.

Clinical anatomy (New York, N.Y.)

Fasel JHD.
PMID: 28791739
Clin Anat. 2017 Oct;30(7):974-977. doi: 10.1002/ca.22974. Epub 2017 Aug 22.

Worldwide, compartmentalization of the human liver into portal venous territories today follows the eight-segments scheme credited to Couinaud. However, there are increasing reports of anatomical, radiological and surgical observations that contradict this concept. This paper presents a viewpoint that...

Cite
Fasel JHD. Human liver territories: Think beyond the 8-segments scheme. Clin Anat. 2017;30(7):974-977doi: 10.1002/ca.22974.
Fasel, J. H. D. (2017). Human liver territories: Think beyond the 8-segments scheme. Clinical anatomy (New York, N.Y.), 30(7), 974-977. https://doi.org/10.1002/ca.22974
Fasel, Jean H D. "Human liver territories: Think beyond the 8-segments scheme." Clinical anatomy (New York, N.Y.) vol. 30,7 (2017): 974-977. doi: https://doi.org/10.1002/ca.22974
Fasel JHD. Human liver territories: Think beyond the 8-segments scheme. Clin Anat. 2017 Oct;30(7):974-977. doi: 10.1002/ca.22974. Epub 2017 Aug 22. PMID: 28791739.
Copy Download .nbib Format: NLM
The utility of ezetimibe therapy in nonalcoholic fatty liver disease.

The Korean journal of internal medicine

Jun BG, Cheon GJ.
PMID: 30840809
Korean J Intern Med. 2019 Mar;34(2):284-285. doi: 10.3904/kjim.2019.043. Epub 2019 Feb 25.

No abstract available.

Cite
Jun BG, Cheon GJ. The utility of ezetimibe therapy in nonalcoholic fatty liver disease. Korean J Intern Med. 2019;34(2):284-285doi: 10.3904/kjim.2019.043.
Jun, B. G., & Cheon, G. J. (2019). The utility of ezetimibe therapy in nonalcoholic fatty liver disease. The Korean journal of internal medicine, 34(2), 284-285. https://doi.org/10.3904/kjim.2019.043
Jun, Baek Gyu, and Cheon, Gab Jin. "The utility of ezetimibe therapy in nonalcoholic fatty liver disease." The Korean journal of internal medicine vol. 34,2 (2019): 284-285. doi: https://doi.org/10.3904/kjim.2019.043
Jun BG, Cheon GJ. The utility of ezetimibe therapy in nonalcoholic fatty liver disease. Korean J Intern Med. 2019 Mar;34(2):284-285. doi: 10.3904/kjim.2019.043. Epub 2019 Feb 25. PMID: 30840809; PMCID: PMC6406096.
Copy Download .nbib Format: NLM
[Absence of the left hepatic lobe].

Der Radiologe

Paech D, Loi L, Piecha F, Bonekamp D, Delorme S, Schlemmer HP, Mueller S.
PMID: 30783702
Radiologe. 2019 Jun;59(6):550-554. doi: 10.1007/s00117-019-0500-2.

No abstract available.

Cite
Paech D, Loi L, Piecha F, et al. Fehlen des linken Leberlappens. [Absence of the left hepatic lobe]. Radiologe. 2019;59(6):550-554doi: 10.1007/s00117-019-0500-2.
Paech, D., Loi, L., Piecha, F., Bonekamp, D., Delorme, S., Schlemmer, H. P., & Mueller, S. (2019). Fehlen des linken Leberlappens. [Absence of the left hepatic lobe]. Der Radiologe, 59(6), 550-554. https://doi.org/10.1007/s00117-019-0500-2
Paech, D, et al. "Fehlen des linken Leberlappens." [Absence of the left hepatic lobe]. Der Radiologe vol. 59,6 (2019): 550-554. doi: https://doi.org/10.1007/s00117-019-0500-2
Paech D, Loi L, Piecha F, Bonekamp D, Delorme S, Schlemmer HP, Mueller S. Fehlen des linken Leberlappens. [Absence of the left hepatic lobe]. Radiologe. 2019 Jun;59(6):550-554. doi: 10.1007/s00117-019-0500-2. German. PMID: 30783702.
Copy Download .nbib Format: NLM
Metabolism: New insights into the BAT-liver-gut axis.

Nature reviews. Endocrinology

Morris A.
PMID: 28664921
Nat Rev Endocrinol. 2017 Aug;13(8):438. doi: 10.1038/nrendo.2017.85. Epub 2017 Jun 30.

No abstract available.

Cite
Morris A. Metabolism: New insights into the BAT-liver-gut axis. Nat Rev Endocrinol. 2017;13(8):438doi: 10.1038/nrendo.2017.85.
Morris, A. (2017). Metabolism: New insights into the BAT-liver-gut axis. Nature reviews. Endocrinology, 13(8), 438. https://doi.org/10.1038/nrendo.2017.85
Morris, Alan. "Metabolism: New insights into the BAT-liver-gut axis." Nature reviews. Endocrinology vol. 13,8 (2017): 438. doi: https://doi.org/10.1038/nrendo.2017.85
Morris A. Metabolism: New insights into the BAT-liver-gut axis. Nat Rev Endocrinol. 2017 Aug;13(8):438. doi: 10.1038/nrendo.2017.85. Epub 2017 Jun 30. PMID: 28664921.
Copy Download .nbib Format: NLM
A Healthy Liver After SVR: Food for Thought.

Digestive diseases and sciences

Rocque B, Kahn J, Emamaullee J.
PMID: 32785795
Dig Dis Sci. 2021 Jun;66(6):1778-1779. doi: 10.1007/s10620-020-06547-1.

No abstract available.

Cite
Rocque B, Kahn J, Emamaullee J. A Healthy Liver After SVR: Food for Thought. Dig Dis Sci. 2021;66(6):1778-1779doi: 10.1007/s10620-020-06547-1.
Rocque, B., Kahn, J., & Emamaullee, J. (2021). A Healthy Liver After SVR: Food for Thought. Digestive diseases and sciences, 66(6), 1778-1779. https://doi.org/10.1007/s10620-020-06547-1
Rocque, Brittany, et al. "A Healthy Liver After SVR: Food for Thought." Digestive diseases and sciences vol. 66,6 (2021): 1778-1779. doi: https://doi.org/10.1007/s10620-020-06547-1
Rocque B, Kahn J, Emamaullee J. A Healthy Liver After SVR: Food for Thought. Dig Dis Sci. 2021 Jun;66(6):1778-1779. doi: 10.1007/s10620-020-06547-1. PMID: 32785795; PMCID: PMC7878581.
Copy Download .nbib Format: NLM
Targeting an energy sensor to prevent energy excess in the liver.

The lancet. Gastroenterology & hepatology

Wong GL, Wong VW.
PMID: 34560016
Lancet Gastroenterol Hepatol. 2021 Nov;6(11):876-877. doi: 10.1016/S2468-1253(21)00307-1. Epub 2021 Sep 22.

No abstract available.

Cite
Wong GL, Wong VW. Targeting an energy sensor to prevent energy excess in the liver. Lancet Gastroenterol Hepatol. 2021;6(11):876-877doi: 10.1016/S2468-1253(21)00307-1.
Wong, G. L., & Wong, V. W. (2021). Targeting an energy sensor to prevent energy excess in the liver. The lancet. Gastroenterology & hepatology, 6(11), 876-877. https://doi.org/10.1016/S2468-1253(21)00307-1
Wong, Grace Lai-Hung, and Wong, Vincent Wai-Sun. "Targeting an energy sensor to prevent energy excess in the liver." The lancet. Gastroenterology & hepatology vol. 6,11 (2021): 876-877. doi: https://doi.org/10.1016/S2468-1253(21)00307-1
Wong GL, Wong VW. Targeting an energy sensor to prevent energy excess in the liver. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):876-877. doi: 10.1016/S2468-1253(21)00307-1. Epub 2021 Sep 22. PMID: 34560016.
Copy Download .nbib Format: NLM
Liver vessel segmentation based on inter-scale V-Net.

Mathematical biosciences and engineering : MBE

Yang J, Fu M, Hu Y.
PMID: 34198439
Math Biosci Eng. 2021 May 18;18(4):4327-4340. doi: 10.3934/mbe.2021217.

Segmentation and visualization of liver vessel is a key task in preoperative planning and computer-aided diagnosis of liver diseases. Due to the irregular structure of liver vessel, accurate liver vessel segmentation is difficult. This paper proposes a method of...

Cite
Yang J, Fu M, Hu Y. Liver vessel segmentation based on inter-scale V-Net. Math Biosci Eng. 2021;18(4):4327-4340doi: 10.3934/mbe.2021217.
Yang, J., Fu, M., & Hu, Y. (2021). Liver vessel segmentation based on inter-scale V-Net. Mathematical biosciences and engineering : MBE, 18(4), 4327-4340. https://doi.org/10.3934/mbe.2021217
Yang, Jinzhu, et al. "Liver vessel segmentation based on inter-scale V-Net." Mathematical biosciences and engineering : MBE vol. 18,4 (2021): 4327-4340. doi: https://doi.org/10.3934/mbe.2021217
Yang J, Fu M, Hu Y. Liver vessel segmentation based on inter-scale V-Net. Math Biosci Eng. 2021 May 18;18(4):4327-4340. doi: 10.3934/mbe.2021217. PMID: 34198439.
Copy Download .nbib Format: NLM
In Reply.

Deutsches Arzteblatt international

Dreher M, Balfanz P, Müller-Wieland D, Marx N.
PMID: 33559590
Dtsch Arztebl Int. 2020 Oct 16;117(42):717-718. doi: 10.3238/arztebl.2020.0717c.

No abstract available.

Cite
Dreher M, Balfanz P, Müller-Wieland D, et al. In Reply. Dtsch Arztebl Int. 2020;117(42):717-718doi: 10.3238/arztebl.2020.0717c.
Dreher, M., Balfanz, P., Müller-Wieland, D., & Marx, N. (2020). In Reply. Deutsches Arzteblatt international, 117(42), 717-718. https://doi.org/10.3238/arztebl.2020.0717c
Dreher, Michael, et al. "In Reply." Deutsches Arzteblatt international vol. 117,42 (2020): 717-718. doi: https://doi.org/10.3238/arztebl.2020.0717c
Dreher M, Balfanz P, Müller-Wieland D, Marx N. In Reply. Dtsch Arztebl Int. 2020 Oct 16;117(42):717-718. doi: 10.3238/arztebl.2020.0717c. PMID: 33559590; PMCID: PMC7868943.
Copy Download .nbib Format: NLM
Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation.

World journal of surgery

Kim M, Kim CW, Hwang S, Kim YH, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC, Han DJ, Lee SG.
PMID: 34235562
World J Surg. 2021 Oct;45(10):3206-3213. doi: 10.1007/s00268-021-06219-9. Epub 2021 Jul 07.

BACKGROUND: The purpose of this study was to evaluate the characteristics and prognosis of de novo CRC patients who underwent liver or kidney transplantation.METHODS: We retrospectively reviewed the medical records of 66 de novo CRC patients selected from 8,734...

Cite
Kim M, Kim CW, Hwang S, et al. Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation. World J Surg. 2021;45(10):3206-3213doi: 10.1007/s00268-021-06219-9.
Kim, M., Kim, C. W., Hwang, S., Kim, Y. H., Lee, J. L., Yoon, Y. S., Park, I. J., Lim, S. B., Yu, C. S., Kim, J. C., Han, D. J., & Lee, S. G. (2021). Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation. World journal of surgery, 45(10), 3206-3213. https://doi.org/10.1007/s00268-021-06219-9
Kim, Minsung, et al. "Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation." World journal of surgery vol. 45,10 (2021): 3206-3213. doi: https://doi.org/10.1007/s00268-021-06219-9
Kim M, Kim CW, Hwang S, Kim YH, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC, Han DJ, Lee SG. Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation. World J Surg. 2021 Oct;45(10):3206-3213. doi: 10.1007/s00268-021-06219-9. Epub 2021 Jul 07. PMID: 34235562.
Copy Download .nbib Format: NLM
A call to action for fatty liver disease.

Liver international : official journal of the International Association for the Study of the Liver

Mantovani A, Valenti L.
PMID: 34002475
Liver Int. 2021 Jun;41(6):1182-1185. doi: 10.1111/liv.14907.

No abstract available.

Cite
Mantovani A, Valenti L. A call to action for fatty liver disease. Liver Int. 2021;41(6):1182-1185doi: 10.1111/liv.14907.
Mantovani, A., & Valenti, L. (2021). A call to action for fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver, 41(6), 1182-1185. https://doi.org/10.1111/liv.14907
Mantovani, Alessandro, and Valenti, Luca. "A call to action for fatty liver disease." Liver international : official journal of the International Association for the Study of the Liver vol. 41,6 (2021): 1182-1185. doi: https://doi.org/10.1111/liv.14907
Mantovani A, Valenti L. A call to action for fatty liver disease. Liver Int. 2021 Jun;41(6):1182-1185. doi: 10.1111/liv.14907. PMID: 34002475.
Copy Download .nbib Format: NLM
Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease.

Computers in biology and medicine

Amanatidou AI, Dedoussis GV.
PMID: 33550014
Comput Biol Med. 2021 Apr;131:104243. doi: 10.1016/j.compbiomed.2021.104243. Epub 2021 Jan 27.

Non-alcoholic fatty liver disease (NAFLD) is a disease with multidimensional complexities. Many attempts have been made over the years to treat this disease but its incidence is rising. For this reason, the need to identify and study new candidate...

Cite
Amanatidou AI, Dedoussis GV. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Comput Biol Med. 2021;131:104243doi: 10.1016/j.compbiomed.2021.104243.
Amanatidou, A. I., & Dedoussis, G. V. (2021). Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Computers in biology and medicine, 131104243. https://doi.org/10.1016/j.compbiomed.2021.104243
Amanatidou, Athina I, and Dedoussis, George V. "Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease." Computers in biology and medicine vol. 131 (2021): 104243. doi: https://doi.org/10.1016/j.compbiomed.2021.104243
Amanatidou AI, Dedoussis GV. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Comput Biol Med. 2021 Apr;131:104243. doi: 10.1016/j.compbiomed.2021.104243. Epub 2021 Jan 27. PMID: 33550014.
Copy Download .nbib Format: NLM
Hepatic T helper 17 cells implicated in NAFLD.

Nature reviews. Endocrinology

Greenhill C.
PMID: 34112983
Nat Rev Endocrinol. 2021 Aug;17(8):449. doi: 10.1038/s41574-021-00525-x.

No abstract available.

Cite
Greenhill C. Hepatic T helper 17 cells implicated in NAFLD. Nat Rev Endocrinol. 2021;17(8):449doi: 10.1038/s41574-021-00525-x.
Greenhill, C. (2021). Hepatic T helper 17 cells implicated in NAFLD. Nature reviews. Endocrinology, 17(8), 449. https://doi.org/10.1038/s41574-021-00525-x
Greenhill, Claire. "Hepatic T helper 17 cells implicated in NAFLD." Nature reviews. Endocrinology vol. 17,8 (2021): 449. doi: https://doi.org/10.1038/s41574-021-00525-x
Greenhill C. Hepatic T helper 17 cells implicated in NAFLD. Nat Rev Endocrinol. 2021 Aug;17(8):449. doi: 10.1038/s41574-021-00525-x. PMID: 34112983.
Copy Download .nbib Format: NLM
Showing 421 to 432 of 432 entries